Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
暂无分享,去创建一个
Y. Nagata | Y. Iwamoto | N. Hattori | M. Yamasaki | T. Masuda | K. Fujitaka | N. Ishikawa | S. Kawase | K. Hamai | N. Imano | N. Matsumoto | H. Shoda | Yoshikazu Awaya | N. Shiota | Tomoko Suzuki | Sayaka Ueno | Soichi Kitaguchi | Y. Nishimura | Wakako Daido | Yusuke Takayama | Masahiko Sumii | Hiroyasu Shoda